These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22970178)

  • 1. Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting.
    Kidd TJ; Ritchie SR; Ramsay KA; Grimwood K; Bell SC; Rainey PB
    PLoS One; 2012; 7(9):e44199. PubMed ID: 22970178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis.
    Kidd TJ; Grimwood K; Ramsay KA; Rainey PB; Bell SC
    J Clin Microbiol; 2011 Jan; 49(1):263-8. PubMed ID: 21084517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre.
    Wee BA; Tai AS; Sherrard LJ; Ben Zakour NL; Hanks KR; Kidd TJ; Ramsay KA; Lamont I; Whiley DM; Bell SC; Beatson SA
    BMC Genomics; 2018 Aug; 19(1):644. PubMed ID: 30165811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection.
    Darch SE; McNally A; Harrison F; Corander J; Barr HL; Paszkiewicz K; Holden S; Fogarty A; Crusz SA; Diggle SP
    Sci Rep; 2015 Jan; 5():7649. PubMed ID: 25578031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform.
    Syrmis MW; Moser RJ; Kidd TJ; Hunt P; Ramsay KA; Bell SC; Wainwright CE; Grimwood K; Nissen MD; Sloots TP; Whiley DM
    J Med Microbiol; 2013 May; 62(Pt 5):734-740. PubMed ID: 23412772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Syrmis MW; Kidd TJ; Moser RJ; Ramsay KA; Gibson KM; Anuj S; Bell SC; Wainwright CE; Grimwood K; Nissen M; Sloots TP; Whiley DM
    BMC Infect Dis; 2014 Jun; 14():307. PubMed ID: 24902856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235.
    Maatallah M; Cheriaa J; Backhrouf A; Iversen A; Grundmann H; Do T; Lanotte P; Mastouri M; Elghmati MS; Rojo F; Mejdi S; Giske CG
    PLoS One; 2011; 6(10):e25617. PubMed ID: 21984923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-sectional and longitudinal multilocus sequence typing of pseudomonas aeruginosa in cystic fibrosis sputum samples.
    Waine DJ; Honeybourne D; Smith EG; Whitehouse JL; Dowson CG
    J Clin Microbiol; 2009 Nov; 47(11):3444-8. PubMed ID: 19710263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraclonal genetic diversity amongst cystic fibrosis and keratitis isolates of Pseudomonas aeruginosa.
    Hall AJ; Fothergill JL; Kaye SB; Neal TJ; McNamara PS; Southern KW; Winstanley C
    J Med Microbiol; 2013 Feb; 62(Pt 2):208-216. PubMed ID: 23105019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
    Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.
    Scott FW; Pitt TL
    J Med Microbiol; 2004 Jul; 53(Pt 7):609-615. PubMed ID: 15184530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland.
    Logan C; Habington A; Lennon G; Grogan J; Byrne M; O'Leary J; O'Sullivan N
    J Med Microbiol; 2012 Jan; 61(Pt 1):64-70. PubMed ID: 21921114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Waters V; Zlosnik JE; Yau YC; Speert DP; Aaron SD; Guttman DS
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3341-50. PubMed ID: 22843295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis.
    Duong J; Booth SC; McCartney NK; Rabin HR; Parkins MD; Storey DG
    PLoS One; 2015; 10(11):e0143466. PubMed ID: 26599104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
    López-Causapé C; de Dios-Caballero J; Cobo M; Escribano A; Asensio Ó; Oliver A; Del Campo R; Cantón R; Solé A; Cortell I; Asensio O; García G; Martínez MT; Cols M; Salcedo A; Vázquez C; Baranda F; Girón R; Quintana E; Delgado I; de Miguel MÁ; García M; Oliva C; Prados MC; Barrio MI; Pastor MD; Olveira C; de Gracia J; Álvarez A; Escribano A; Castillo S; Figuerola J; Togores B; Oliver A; López C; de Dios Caballero J; Tato M; Máiz L; Suárez L; Cantón R
    Int J Antimicrob Agents; 2017 Sep; 50(3):334-341. PubMed ID: 28735882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular typing and epidemiological investigation of clinical populations of Pseudomonas aeruginosa using an oligonucleotide-microarray.
    Ballarini A; Scalet G; Kos M; Cramer N; Wiehlmann L; Jousson O
    BMC Microbiol; 2012 Jul; 12():152. PubMed ID: 22840192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis.
    Anuj SN; Whiley DM; Kidd TJ; Ramsay KA; Bell SC; Syrmis MW; Grimwood K; Wainwright CE; Nissen MD; Sloots TP
    Clin Microbiol Infect; 2011 Sep; 17(9):1403-8. PubMed ID: 21129101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
    Finnan S; Morrissey JP; O'Gara F; Boyd EF
    J Clin Microbiol; 2004 Dec; 42(12):5783-92. PubMed ID: 15583313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting.
    Abdul Wahab A; Taj-Aldeen SJ; Hagen F; Diophode S; Saadoon A; Meis JF; Klaassen CH
    Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):265-71. PubMed ID: 23996049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.